Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm showing 85,000 shares on the bid for the U.S. side. Good to see that.
I think you're confused. Jim Marcelli hasn't put a penny into this company. The post you're referencing is about Ross Fasick. Fasick and Ron Bucchi are only one's at Lightwave who've put any real money at risk.
Professor leads photonics revolution to help researchers access high-tech foundry services.
This is a good Hochberg/Opsis article. http://phys.org/news/2012-10-professor-photonics-revolution-access-high-tech.html?goback=%2Egde_1416467_member_177385363
Lightwave is very fortunate to be working close by all this. Remember that University of Delaware has a strategic alignment with Delaware Technology Park, where out lab is located. I don't believe Hochberg unaware of Lightwave. Though it would be in his best interest to say so if contacted by a random investor.
You are right Lightwave does not need another CEO swap, unless Paul Otellini wants the job. Short of some heavy hitter taking the position it would only result in more setbacks. Time would be wasted while the new CEO evaluated the company and made changes to suit his leadership vision. Lightwave is coming to a tipping point with the Celestech contract, merger/acquisition and LSS coupons. I don't doubt Tom is in control and able to manage people. That should be his strongest skill considering his background. As for his business sense it's hard to speculate on that. Time will tell.
When conversation provides the opportunity I tell every fat person I can about Belviq. They have all been interested.
Arena Short Interest Declines - So Do Hopes Of A Squeeze
http://m.seekingalpha.com/article/1106701-arena-short-interest-declines-so-do-hopes-of-a-squeeze?source=email_rt_article_title
Alli is probably my favorite weight loss method to read reviews about, but the Sensa ones on Amazon are pretty good.
Hopefully this year champagne will replace state police.
Yea, that would make a lot more sense. I'll add it though.
Buzz, did you see my post about Simmons not teaching at Bama this semester? It got buried pretty fast.
I'm glad to see that you made it to this board dlucky and you're welcome. I am taking every opinion into consideration since we have such a smart group of people here, but I do not feel discouraged.
I want to say thank you to everyone who has contacted me off the board thus far to show support. I planned to curb the tone down, being abrasive will be counter productive. "you catch more flies with honey"
As far as the LSS, I'm not sure. When Tom said "we only get one try" I thought that was kind of out of place. This being a one shot deal doesn't add up. The LSS has it easy, no money out of pocket and they just have to test what we send in. Personally, I think Tom said that to "help" us not mind waiting so long for them perfect everything in order to get the pieces coated.
I have a great deal of faith in the lab team, especially Dave Eaton. Obviously Mickelson too. They won't cut any corners. At the SHM Eaton said it wasn't a matter of if but when as far as commercially acceptable purity. The 12/31 update makes it sound like Mickelson has the thin film coatings where the LSS wants them. So assuming everything is working properly the LSS should cut some type of deal. Even if they did not intend to use the material in its exact form they should want to add what we have to their patent portfolio.
I'm not sure when they'll send in the LSS coupons. If I had to guess I would say early March.
Edit. Nvm, waste of ones time.
Looking at the chart from last year the volume didn't start to come in until around January 17th, share price started to move up around the 9th of January with the strength running through the whole month of February. The year before that it stayed even until around mid February before running up. It should be interesting to see what will happen in the next 2 months.
The timeline for the expansion is in our favor.
It seems Intel is preparing for that. http://www.oregonlive.com/silicon-forest/index.ssf/2012/10/intel_set_to_expand_its_hillsb.html
That makes sense clawmann, I think it's safe to assume that is the case.
Could you give me an example of a paid promotion?
I thought we might get close to $10.50 today. Whamp whaaaa. I also am still hopeful for a PR after close. Then the CEO can have something fresh for the conference.
Good point Gates, I always enjoy reading your posts. If they are that busy there would be no time for dealing with the headaches of finding a replacement. I was viewing Steve and his salary as one more staff member for the lab, but who knows if they can even fit anymore people in there.
Gates, do you think an important part of improving communications with current and potential shareholders would involve employing someone who consistently responds to emails sent to info@lightwavelogic.com?
That's a great article Gatesoft. I came across this today, also a good read.
http://www.forbes.com/sites/joshwolfe/2012/12/13/why-ibm-and-intel-are-chasing-the-100b-opportunity-in-nanophotonics/
Howard Simmons is not teaching at Alabama this semester. I got this from the head of the Chemistry department.
I thought you were referring to shares sold. I meant by selling too early, not that you lost money.
Somehow I feel like you just got played again.
Great idea Snez. If anyone else wishes to have their real name added they can post it or email me at inversor86@yahoo.com.
I edited the previous post to include this info with about 1 minute to spare in the edit window, sorry for the typo.
EVERYONE READ.
Six, I would gladly submit the questions. If everyone can post their questions in a timely manner I can also mail out a copy for each Independent Director. Following the specified channel they should reach everyone before the CC.
If you would like your name this please post it or email me
inversor86@yahoo.com
If you prefer you can also email me your questions for the list.
Lightwave's IR person, Steve Cordovano, does not usually answer or acknowledge questions. At least not mine.
Though in his defense he is probably very busy running back and forth between his company in NYC and his home in Connecticut.
What has Joe Miller specifically done to help Lightwave since the shareholders meeting?
What is Charles Olson doing?
Why was someone hired for sales and marketing years before the materials were ready to sell or market?
How is Steve Cordovano's six figure salary justified when he won't respond to simple investor inquiries?
What are some recent examples of efforts made to bring awareness to new investors?
When does Dr. Mickelson's contract with Lightwave expire?
I bet if we send these questions in early we won't get a conference call. LOL
Get the F out. That's a great idea, they are so many fat kids out there. Arena/Flintstones combo.
Today's Featured Drugs Laggard, Arena Pharmaceuticals
j/k
I made a couple phone calls, I should have his course(s) tomorrow.
6.5 million shares already traded and it's at 9.41 lol. Only ARNA.
Reply from Stephan.
I called it.
Hi Michael,
Thanks for your email. I am currently on PTO and back next week.
I will make sure to contact you then.
Have a nice day
Regards
Stephan.
Also, Simmons is down is Adjunct staff, aka part time.
Just a thought but this merger might be much closer than we were led to believe. Tom would be smart to be reserved about what he said in the update as to not put himself in a bad negotiating position before everything is final. He can't tell us things are imminent while still sorting out dollars and cents. Simmons being part time help anyway may be expecting to be replaced. If so I can see why he would have this lined up.
Either way I think an email to Tom tomorrow asking why one of Lightwave's people is working somewhere we ended our relationship is in order. And also how about a detailed explanation as to why that relationship was ended.
The CEO is one of the reasons I bought this stock. Dolphin, has a history of building up a company and then selling it. This is the fourth company he has run, the previous 3 he grew and sold "when appropriate" as he said in the video in post #3 of this page. No doubt that Avita would be the largest assuming things go as planned.
Here's his Bio:
Dr. William Ford Dolphin, Ph.D has been the Chief Executive Officer of Avita Medical Limited since March 05, 2008 and Managing Director since June 2008. Dr. Dolphin served as the Chief Executive Officer and President of SonaMed Corporation. Dr. Dolphin served as the Chief Executive Officer of Visiomed Group Ltd. since February 2005. He served as the President and Chief Technology Officer of a US-based contract research and development company. He also served as the Chairman of the Board, Chief Executive Officer and President of a US medical device company. He served as the Chief Executive Officer of a technology joint venture. He has been a Director at Avita Medical since March 5, 2008. He served as an Executive Director at Visiomed since April 1, 2005. He served as a Director of numerous companies in the US, NZ and Australia. He was Professor in the Departments of Biomedical Engineering and Biology at Boston University. He is the author of more than 60 peer-reviewed scientific articles. He holds 5 US and international patents. He was twice recipient of the National Research Service Award from the National Institutes of Health. Dr. Dolphin holds a PhD in Biophysics from the Boston University in 1989.
For me I place a lot of weight on how much I "like" the CEO, too many crooks and paycheck collectors are running companies, and I am very wary of that. To get personal, at one point I was into studying how to analyze people's behaviors and personality traits. I was building upon my own natural ability to read people. I got very good at it. I like Dolphin, he always presents himself consistently. His IQ seems to be very high, probably in the low 140s and he's full of energy. Most importantly he doesn't lie or BS anyone in the interviews that I've seen, always honest and straightforward. Even when the questions are weak or coming out slow he is respectful and doesn't give the impression that his time is being wasted (so he's not arrogant, important). A genuine person with a genuine belief in the company. Dolphin also makes himself available to shareholders, which is another positive. If you would like his email address I can give it to you.
While I don't know a great deal about this person, I know that Avita hired a big gun for doing sales in China. On the BOD no major league hitters here. But Dolphin seems to very conscientious about spending and as Avita progresses I imagine they'll replace people.
The Chairman Dalton Gooding was a partner at Ernst & Young which should provide some nice connections in the health care industry here in the U.S. Dr. Watt is someone Dolphin brought with him from a previous company he ran. Dr. Fiona Wood non-exec director, she discovered Re-Cell. I get the feeling she is a do-gooder which could be counter productive to real business, but probably a good speaker to the medical field so it's an even break there.
COO -Tim Rooney, I like him, good bit of experience. He was a COO/CFO of a pharmaceutical whole sale company and was there from startup to it being a half billion $ company.
GM Asia Pacific - Lorraine Glover, not much out there about her, she's been with the company for over a decade.
The rest of the management are difficult to find background info on.
Honestly, one good write up from a major news network in the U.S. and we'll get a nice run. Check out what happened to CTIX a couple weeks ago when the New York Times did a piece on them.
The CEO brought this up in the December letter to Shareholders.
"Management feels strongly that the recent share price does not reflect the company's stage of development or recent progress made by Avita. In the coming months we will be working with potential institutional investors to increase Avita's visibility in financial markets and build shareholder value."
A while back I accessed the burn market in the U.S. and concluded it was a little over $2 billion as a whole. About 1.1 million burns require medical treatment each year. The majority of money is spent on 2nd degree burns, which is what Re-Cell is intended for. I think it's fair to say they're after a 1 billion dollar market in the U.S. Hard to say what worldwide would be in that respect. 3x maybe?
Something that I had not paid much attention to was the leg ulcer market. Re-Cell is in a study right now in the UK for leg ulcer repair using Re-Cell. The initial results were really impressive. I believe Avita stated that was a $1 billion + market in and of itself.
Right now the most important thing is to watch and see how sales in China are.
The primary goal is to get FDA approval for Re-Cell and start marketing it here. Interestingly enough the government organization that provided the most recent funding is also the same group whose doctors are conducting the trial...
The military is supporting it so heavily there is no doubt they'll use it exclusively post FDA, the rest of the market should follow. I agree with valuation I posted here that post FDA a PPS close $8 will be what to expect. FDA approval will be a big boost in Re-Cell's credibility everywhere else it is available, which will help sales. I bet that this moves to $4.50 or so right up to the trial results.
They have the FDA trial for scar repair inline for 2014, intending to use Re-Cell profits to foot the bill. That is the ultimate market in my opinion. The acne scar market alone is massive, but all scarring as a whole. I couldn't even guess. Everyone has a scar they don't want on their body. And you make a good point about breast implants, that's the worst part about them is the scarring. Strippers and porn stars lose a lot in lost wages waiting for their scars to heal. Funny to say, but it's true.
No reply. But keep in mind the holiday structure over there. He's probably on paid leave until mid January.
Off Topic - Smart phone users
Just a suggestion, go to your app market place and download the IHub app. It will notify you whenever someone responds to one of your posts on Investors Hub. This can be very handy if you post on multiple boards.
There is a logical explanation for most of "why did they say we would..." and it's that Lightwave wasn't aware that the materials they were producing weren't consistent enough.
They send a batch to the University for testing and the results were great, they would high 5 each other. They sent another batch and the results weren't the same. Some might say they were "intriguing." They realize they can't get this problem squared away without a proper lab and testing facility as well as more staff. So they took care of all that.
If I'm right the only thing the company didn't do is explain they made a mistake assuming they had repeatability when they didn't. The U.S. military isn't known for admitting their mistakes. Our CEO is a retired Admiral, coincidence?
I was reading about CUSIP #'s. It's a new term for me, a really good idea Bull.
Probably best to hold off on organizing anything until at least after Tom's self-imposed 1 month window for a possible conference call has passed. January 31st is on a Thursay so keep that day clear for it.
And Tom should say one way or the other if they're having a conference call. Rather than make himself look indecisive. "discussing the possibility of" It's a conference call, it shouldn't require much thought or discussion.